Previous cost of control analyses published in the US setting for GLP-1 receptor agonists once-weekly semaglutide and liraglutide have demonstrated the value of the cost of control approach, offering pertinent information to healthcare payers focused on short-term budgets [14,15,16,17]
For compounded tirzepatide with a 90-day BUD, do not stockpile more than a 90-day supply at a time
SEMAGLUTIDE is a GLP-1 (glucagon-like peptide-1) analog that helps reduce appetite, slow stomach emptying, and improve blood sugar control, thus facilitating weight loss and diabetes management
Individual Health Variations Every individual is different, and so is their bodys response to medication
Single-pathway GLP-1 receptor agonists are the older, established class